Results 91 to 100 of about 32,848 (294)
JAMA Network Open, 2020 Key Points Question Is the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to primary cytoreductive surgery (PCS) associated with better outcomes for patients with stage III epithelial ovarian cancer?
Z. Lei +16 more
semanticscholar +1 more source
International Journal of Molecular Sciences, 2021 Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with ...
M. Zaballos +12 more
semanticscholar +1 more source
Colorectal Disease, Volume 28, Issue 1, January 2026.Abstract Aim Pelvic exenteration (PE) is the only curative option for extensive pelvic cancers. Advances have facilitated increasingly complex resectional and reconstructive components, including per‐operative oncological adjuncts such as intraoperative radiotherapy.
Charles T. West +8 more
wiley +1 more source
International Journal of Hyperthermia, 2021 Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after cytoreductive surgery (CRS).
Daan R Löke +8 more
semanticscholar +1 more source
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy [PDF]
Indian Journal of Surgical Oncology, 2016 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) combined have been recognized as standard of care for treatment of a subset of patients with peritoneal carcinomatosis (PC). The aim of CRS is to eliminate all macroscopic disease through a series of visceral resections followed by targeting any residual microscopic ...
S. J. Valle +5 more
openaire +2 more sources
Analgesia for Thoracic Surgery: Does Intraoperative Methadone Deserve a Place?
ANZ Journal of Surgery, Volume 95, Issue 11, Page 2253-2255, November 2025.Intraoperative methadone: potential benefits and considerations for thoracic surgery analgesia.
Eugene Constantine Lai +5 more
wiley +1 more source
World Journal of Surgical Oncology, 2019 Background This study aimed to evaluate the clinical outcomes of concurrent liver resection with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer patients with synchronous liver and peritoneal metastases.
Youngbae Jeon +3 more
doaj +1 more source
Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers
Journal of Surgical Oncology, Volume 132, Issue 5, Page 789-809, October 2025.ABSTRACT Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines.
Ada I. Ozcan +4 more
wiley +1 more source
Case Reports in Oncology, 2016 Cytoreductive surgery (CRS) with hyperthermic intraperitoneal (IP) chemotherapy (HIPEC) is believed to improve outcomes in well-selected patients with peritoneal carcinomatosis.
Jessica Sayuri Tsukamoto +2 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2020 Aim: We sought to determine the epidemiology of mucinous ovarian tumors, the correlation between serum biomarkers and tumor status, and the outcomes of the management in different subtypes of mucinous ovarian tumors in a Chinese surgical cohort. Methods:
Yuanyuan Zhang PhD +8 more
doaj +1 more source